Advertisement

Topics

Chugai Pharma Europe Ltd Company Profile

00:27 EST 24th November 2017 | BioPortfolio

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic antibody biotechnology through over-the-counter medicines to consumer healthcare products.
Chugai is currently the 5th ranked pharmaceutical company in Japan in terms of sales, (the world’s second largest pharmaceutical market after the USA).
On 1st October 2002, Chugai Pharmaceutical Co became a member of the Roche Group, and is Roche’s sole representative in Japan following the integration of Nippon Roche and Chugai.
One of the first examples of specific collaboration between Chugai and Roche is that of MRA: Chugai’s monoclonal antibody in development for the treatment of a number of conditions (eg Rheumatoid Arthritis).
Chugai conducts research at its Japanese research sites employing cutting-edge techniques for identification of small molecule and biological therapeutic candidates.

Location

Mulliner House
Turnham Green
London
W4 1NN
United Kingdom

Contact

Phone: 44 (0) 20 8987 5600
Fax: 44 (0) 20 8987 5660
Email: info@chugai-pharm.co.uk


News Articles [723 Associated News Articles listed on BioPortfolio]

Tokyo drift? Large molecule R&D shortfall threat to Japanese pharma, says Chugai

A failure to embrace biologics R&D has restricted Japanese pharma’s global growth, says CEO of Roche subsidiary Chugai Pharmaceuticals.

Arbitration against Chugai commenced

Japanese drug major Chugai Pharmaceutical today announced that an arbitration against Chugai has been…

Roche and Chugai Pharma report positive Phase III results of haemophilia A drug

Roche and UK-based Chugai Pharmaceutical have reported positive data from the Phase III HAVEN 1 clinical trial of emicizumab in patients suffering from haemophilia A.

Chugai files lawsuit to protect its Herceptin

Japan’s Chugai Pharmaceutical saw its shares gain 2.15% to 4,515 yen, after it revealed legislation…

Chugai applies for additional indication for breast cancer drug in Japan

Chugai has filed an application with the Japanese Ministry of Health, Labor and Welfare (MHLW) for the…

Chugai's Emicizumab Receives Priority Review Designation by FDA for Hemophilia A with Inhibitors

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the US Food and Drugs Administration (FDA) has accepted the Biologics License Application (BLA) and has gr...

Chugai sheds older products to focus on innovation

Japan’s Chugai Pharmaceutical is to sell 13 so-called long-listed products - branded drugs that are…

Chugai's Head of Science and Strategy to Speak at Medtech & Pharma Platform Conference

Chugai Pharma USA, Inc. (CPUSA), a wholly-owned subsidiary of Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) leading the planning and execution of early-stage global clinical...

Drugs and Medications [246 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [392 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).

Airway stenting (AS) commenced in Europe circa 1987 with the first placement of a dedicated silicone airway stent. Subsequently, over the last 3 decades, AS was spread throughout Europe, using differe...

AI-powered drug discovery captures pharma interest.

Clinical Trials Series - Large Pharma.

Clinical Trials [589 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

THE STUDY WILL BE A TWO-PART RESEARCH PART A and PART A extended: 1. To implement a "common" MRI acquisition protocol in multiple centers across Europe (Pharma-COG partners)...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1521 Associated Companies listed on BioPortfolio]

Chugai Pharma Europe Limited

European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.

Chugai Pharma Europe Ltd

Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...

Chugai Pharma USA, Inc.

Astellas Pharma Canada, Inc.

Astellas Pharma Europe Ltd., located in the UK, is the European Headquarters of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the he...

Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around...

More Information about "Chugai Pharma Europe Ltd" on BioPortfolio

We have published hundreds of Chugai Pharma Europe Ltd news stories on BioPortfolio along with dozens of Chugai Pharma Europe Ltd Clinical Trials and PubMed Articles about Chugai Pharma Europe Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharma Europe Ltd Companies in our database. You can also find out about relevant Chugai Pharma Europe Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record